oleanolic acid has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Distler, JH; Doniparthi, S; Hinchcliff, M; Komura, K; Lord, G; Tamaki, Z; Tomcik, M; Varga, J; Wang, W; Wei, J; Zhu, H | 1 |
| Allaway, G; Bhattachayya, M; Biswal, SS; Jones, BM; Korman, B; Lord, G; Marangoni, RG; Tourtellotte, WG; Varga, J; Wei, J; Zhu, H | 1 |
2 other study(ies) available for oleanolic acid and Sclerosis, Systemic
| Article | Year |
|---|---|
A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
Topics: Adipogenesis; Adult; Animals; Biopsy; Cells, Cultured; Collagen; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fibroblasts; Fibrosis; Humans; Infant, Newborn; Mice; Mice, Inbred C57BL; Oleanolic Acid; Organ Culture Techniques; PPAR gamma; Proto-Oncogene Proteins c-akt; Scleroderma, Systemic; Signal Transduction; Skin; Transforming Growth Factor beta | 2014 |
Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative.
Topics: Animals; Bleomycin; Cells, Cultured; Chalcones; Down-Regulation; Fibroblasts; Fibrosis; Gene Expression Regulation; Genetic Predisposition to Disease; Humans; Mice; Mice, Knockout; NF-E2-Related Factor 2; Oleanolic Acid; RNA, Messenger; Scleroderma, Systemic; Transforming Growth Factor beta | 2017 |